How are collaborations between the DeNDRoN and industry established?
Introdution:
Introdution:
DeNDRoN offers two levels of service
to support start up of an industry trial, as well as general advice for running
clinical research in Dementia, Parkinson’s Disease, Motor Neurone Disease &
Huntington’s Disease. The sponsor should make initial
approaches to the co-ordinating centre, to discuss the role
of DeNDRoN in supporting clinical research and discuss any non-study specific
requirements. A UKCRN confidentiality agreement
must then be agreed, to meet all parties’ requirements and signed off with the
UKCRN industry team, in order to transfer confidential documents and discuss
study requirements in detail. This agreement is necessary if you
wish the study to undergo any review, prior to study adoption.